Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unknown Primary Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT04584008
What this trial is testing

Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics

Who this might be right for
Biliary Tract NeoplasmsGastric CancerEsophageal Squamous Cell Carcinoma+6 more
Peking University 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06869174
What this trial is testing

Pucotenlimab Combined with MRG002 for HER2-positive Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown Primary
Zhiguo Luo, MD, PhD 50
Not applicableLooking for participantsNCT07524114
What this trial is testing

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

Who this might be right for
Breast CancerLung CancerMelanoma+7 more
University Health Network, Toronto 7,000
Testing effectiveness (Phase 2)Ended earlyNCT07061080
What this trial is testing

Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab

Who this might be right for
Advanced Neuroendocrine Carcinomas of The Digestive SystemAdvanced Neuroendocrine Carcinomas Unknown Primary Origin
Grupo Espanol de Tumores Neuroendocrinos 1
Not applicableStudy completedNCT04028479
What this trial is testing

The Registry of Oncology Outcomes Associated With Testing and Treatment

Who this might be right for
AdenocarcinomaAdenocystic CarcinomaAnal Cancer+73 more
Taproot Health 167
Not applicableStudy completedNCT00269373
What this trial is testing

Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Who this might be right for
Unknown Primary Tumor
Rigshospitalet, Denmark 136
Early research (Phase 1)Study completedNCT00004178
What this trial is testing

Gene Therapy in Treating Patients With Cancer

Who this might be right for
Cancer
Roger Williams Medical Center
Testing effectiveness (Phase 2)Study completedNCT00191503
What this trial is testing

Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma

Who this might be right for
Adenocarcinoma
Eli Lilly and Company 30
Testing effectiveness (Phase 2)Looking for participantsNCT04325425
What this trial is testing

Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPancreatic And Unknown Primary

Who this might be right for
Neuroendocrine Carcinoma
Centre Hospitalier Universitaire Dijon 218
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Not applicableLooking for participantsNCT06695494
What this trial is testing

Enabling Genomic Testing in Cancer of Unknown Primary

Who this might be right for
Cancer of Unknown PrimaryNeoplasm, Unknown Primary
The Christie NHS Foundation Trust 100
Testing effectiveness (Phase 2)Study completedNCT00353145
What this trial is testing

Gemox as First and Second Line Therapy in Unknown Primary Cancer

Who this might be right for
Unknown Primary Neoplasms
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)WithdrawnNCT00458315
What this trial is testing

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Who this might be right for
Unknown Primary Tumors
Rigshospitalet, Denmark
Testing effectiveness (Phase 2)Looking for participantsNCT05576974
What this trial is testing

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Who this might be right for
Head and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma
University of Texas Southwestern Medical Center 120
Post-approval studies (Phase 4)UnknownNCT01469026
What this trial is testing

CUP Project PET/CT

Who this might be right for
Metastasising Cancer of Unknown Primary
Odense University Hospital 220
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Not applicableUnknownNCT00302588
What this trial is testing

The Final Diagnosis and Treatment Result of Metastatic Cervical Carcinoma of Unknown Primary

Who this might be right for
Metastasis Cervical Lymph Nodes of Unknown Primary Carcinoma
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Study completedNCT02607202
What this trial is testing

Nab-paclitaxel-based Doublet as First Line Therapy in Patients With Cancer of Unknown Primary (CUP)

Who this might be right for
Unknown Primary Tumors
Fondazione del Piemonte per l'Oncologia 57
Not applicableLooking for participantsNCT06644716
What this trial is testing

[18F]F-FAPI PET-CT to Identify Carcinoma of Unknown Primary Origin

Who this might be right for
Cancer of Unknown Primary
Erasmus Medical Center 50
Testing effectiveness (Phase 2)UnknownNCT04131621
What this trial is testing

Nivolumab/Ipilimumab in Second Line CUP-syndrome

Who this might be right for
Cancer of Unknown Primary Site
University Hospital Heidelberg 194
Next Page